Tharimmune Performance
| THARDelisted Stock | 4.95 0.21 4.43% |
Tharimmune holds a performance score of 17 on a scale of zero to a hundred. The entity has a beta of 2.17, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Tharimmune will likely underperform. Use Tharimmune value at risk, and the relationship between the jensen alpha and skewness , to analyze future returns on Tharimmune.
Risk-Adjusted Performance
Solid
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Tharimmune are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Tharimmune reported solid returns over the last few months and may actually be approaching a breakup point. ...more
1 | Insider Trading | 12/03/2025 |
2 | Bravado on railway tracks Internet questions irresponsible trait of Thar-owners, Not a car... | 12/18/2025 |
3 | Tharimmune files for mixed shelf of up to 2.0 bln - SEC filing - MarketScreener | 01/09/2026 |
4 | Tharimmune Addresses Nasdaq Board Independence Compliance Notice - TipRanks | 01/15/2026 |
5 | Tharimmune, Inc. Announces Pricing of 55 Million Underwritten Registered Offering | 01/20/2026 |
6 | Tharimmune, Inc. Announces Closing of 55 Million Underwritten Registered Direct Offering | 01/22/2026 |
7 | Tharimmune Gains Approval To Run Super Validator On Canton Network - Nasdaq | 01/29/2026 |
8 | Tharimmune, Inc. Announces Corporate Rebrand to Canton Strategic Holdings, Inc., Marking Milestone in Canton Network Digital Asset Treasury Strategy | 02/17/2026 |
Tharimmune |
Tharimmune Relative Risk vs. Return Landscape
If you would invest 245.00 in Tharimmune on November 21, 2025 and sell it today you would earn a total of 250.00 from holding Tharimmune or generate 102.04% return on investment over 90 days. Tharimmune is currently generating 1.3858% in daily expected returns and assumes 6.1488% risk (volatility on return distribution) over the 90 days horizon. In different words, 55% of stocks are less volatile than Tharimmune, and 73% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Tharimmune Target Price Odds to finish over Current Price
The tendency of Tharimmune Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 4.95 | 90 days | 4.95 | about 1.82 |
Based on a normal probability distribution, the odds of Tharimmune to move above the current price in 90 days from now is about 1.82 (This Tharimmune probability density function shows the probability of Tharimmune Stock to fall within a particular range of prices over 90 days) .
Tharimmune Price Density |
| Price |
Predictive Modules for Tharimmune
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Tharimmune. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Tharimmune Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Tharimmune is not an exception. The market had few large corrections towards the Tharimmune's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Tharimmune, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Tharimmune within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.76 | |
β | Beta against Dow Jones | 2.17 | |
σ | Overall volatility | 0.86 | |
Ir | Information ratio | 0.13 |
Tharimmune Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Tharimmune for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Tharimmune can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Tharimmune is now traded under the symbol CNTN. Please update your portfolios or report it if you believe this is an error. Report It! | |
| Tharimmune is way too risky over 90 days horizon | |
| Tharimmune appears to be risky and price may revert if volatility continues | |
| Tharimmune has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (12.2 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Tharimmune generates negative cash flow from operations | |
| About 23.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from prnewswire.com: Tharimmune, Inc. Announces Corporate Rebrand to Canton Strategic Holdings, Inc., Marking Milestone in Canton Network Digital Asset Treasury Strategy |
Tharimmune Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Tharimmune Stock often depends not only on the future outlook of the current and potential Tharimmune's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Tharimmune's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.3 M | |
| Cash And Short Term Investments | 3.6 M |
Tharimmune Fundamentals Growth
Tharimmune Stock prices reflect investors' perceptions of the future prospects and financial health of Tharimmune, and Tharimmune fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Tharimmune Stock performance.
| Return On Equity | -2.25 | ||||
| Return On Asset | -1.0 | ||||
| Current Valuation | 169.64 M | ||||
| Shares Outstanding | 39.53 M | ||||
| Price To Book | 28.74 X | ||||
| EBITDA | (12.43 M) | ||||
| Total Debt | 2.41 M | ||||
| Book Value Per Share | 0.85 X | ||||
| Cash Flow From Operations | (10.9 M) | ||||
| Earnings Per Share | (3.68) X | ||||
| Total Asset | 3.72 M | ||||
| Retained Earnings | (36.9 M) | ||||
About Tharimmune Performance
Assessing Tharimmune's fundamental ratios provides investors with valuable insights into Tharimmune's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Tharimmune is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Things to note about Tharimmune performance evaluation
Checking the ongoing alerts about Tharimmune for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Tharimmune help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Tharimmune is now traded under the symbol CNTN. Please update your portfolios or report it if you believe this is an error. Report It! | |
| Tharimmune is way too risky over 90 days horizon | |
| Tharimmune appears to be risky and price may revert if volatility continues | |
| Tharimmune has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (12.2 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Tharimmune generates negative cash flow from operations | |
| About 23.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from prnewswire.com: Tharimmune, Inc. Announces Corporate Rebrand to Canton Strategic Holdings, Inc., Marking Milestone in Canton Network Digital Asset Treasury Strategy |
- Analyzing Tharimmune's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Tharimmune's stock is overvalued or undervalued compared to its peers.
- Examining Tharimmune's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Tharimmune's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Tharimmune's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Tharimmune's stock. These opinions can provide insight into Tharimmune's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tharimmune. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Consideration for investing in Tharimmune Stock
If you are still planning to invest in Tharimmune check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tharimmune's history and understand the potential risks before investing.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |